Rightmove is the British economy's latest casualty. Sticky inflation, high interest rates and tepid house price growth are squeezing developers, with many projects delayed or abandoned. New builds ...
Zenith Minerals Limited (ZNC) options are a category of derivatives that give the holder the right, but not the obligation, to buy or sell the underlying security for a predefined exercise price (or ...
What is the current share price of Abacus Group (ABG)? Abacus Group's (ABG) current share price is $0.81. This constitutes a price movement of 0.61% when compared to the share price 7 days ago and is ...
What is the current share price of Clinuvel Pharmaceuticals Limited (CUV)? Clinuvel Pharmaceuticals Limited's (CUV) current share price is $8.10. This constitutes a price movement of 1.94% when ...
What is the current share price of Bapcor Limited (BAP)? Bapcor Limited's (BAP) current share price is $0.82. This constitutes a price movement of 3.55% when compared to the share price 7 days ago and ...
What is the current share price of Symal Group Limited (SYL)? Symal Group Limited's (SYL) current share price is $2.71. This constitutes a price movement of 0.73% when compared to the share price 7 ...
A Walkley Award-winning business journalist and Australia's best known shareholder activist, Stephen Mayne has asked questions at more than 1000 AGMs since 1998, all facilitated by owning one of the ...
Investor neglect gave us a fleeting chance to buy the networks cheaply. That's now gone.
Hi, everyone, Stephen Mayne here. This week's CEO interview is with Jon Pilcher, the Chief Executive Officer and Managing Director of Neuren Pharmaceuticals Ltd, a very interesting New Zealand company ...
It's no secret why investors love family-run companies. Just look at those built by the Stokes, Wilsons and Millners. They've amassed generational fortunes through patience, frugality, control and ...
IMPORTANT: This information is general financial product advice only and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. You ...
If you want to be an above average investor, it may pay to play dead. That was the conclusion of a study by US fund manager Fidelity, according to a 2014 article on Business Insider. Fidelity analysed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results